Literature DB >> 16432557

Analytical and biological variables influencing quantitative hepatitis C virus (HCV) measurement in HIV-HCV coinfection.

C L Cooper1, Curtis L Cooper, Paul MacPherson, William Cameron.   

Abstract

The present review considers issues pertaining to the precision and variability of quantitative hepatitis C virus (HCV) measurement in general, outlines the characteristics of HCV RNA in HIV-HCV coinfection and evaluates those factors which may affect this measure. The clinical relevance of accurate HCV measurement in HIV-HCV coinfection is discussed.

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16432557      PMCID： PMC2538965          DOI： 10.1155/2006/187241

Source DB:  PubMed          Journal:  Can J Gastroenterol        ISSN： 0835-7900            Impact factor:   3.522


  52 in total

1.  A new step toward standardization of serum hepatitis C virus-RNA quantification in patients with chronic hepatitis C.

Authors:  M Martinot-Peignoux; N Boyer; V Le Breton; G Le Guludec; C Castelnau; R Akremi; P Marcellin
Journal:  Hepatology       Date:  2000-03       Impact factor: 17.425

2.  Effects of handling and storage of blood on the stability of hepatitis C virus RNA: implications for NAT testing in transfusion practice.

Authors:  P R Grant; A Kitchen; J A Barbara; P Hewitt; C M Sims; J A Garson; R S Tedder
Journal:  Vox Sang       Date:  2000       Impact factor: 2.144

3.  Increase in hepatitis C virus load in hemophiliacs during treatment with highly active antiretroviral therapy.

Authors:  M V Ragni; F A Bontempo
Journal:  J Infect Dis       Date:  1999-12       Impact factor: 5.226

4.  Analysis of the viability of freezer stored serum samples for hepatitis C virus RNA analysis by the SUPERQUANT method: results of a 16 year retrospective study.

Authors:  P Schmid; M Tong; A Conrad; J McHutchison; L M Blatt
Journal:  J Virol Methods       Date:  1999-10       Impact factor: 2.014

5.  Effect of alcohol use and highly active antiretroviral therapy on plasma levels of hepatitis C virus (HCV) in patients coinfected with HIV and HCV.

Authors:  Curtis L Cooper; D William Cameron
Journal:  Clin Infect Dis       Date:  2005-07-01       Impact factor: 9.079

6.  Virus load and risk of heterosexual transmission of human immunodeficiency virus and hepatitis C virus by men with hemophilia. The Multicenter Hemophilia Cohort Study.

Authors:  M Hisada; T R O'Brien; P S Rosenberg; J J Goedert
Journal:  J Infect Dis       Date:  2000-04-07       Impact factor: 5.226

7.  Fluctuation patterns of HCV-RNA serum level in patients with chronic hepatitis C.

Authors:  Y Arase; K Ikeda; K Chayama; N Murashima; A Tsubota; Y Suzuki; S Saitoh; M Kobayashi; M Kobayashi; F Suzuki; H Kumada
Journal:  J Gastroenterol       Date:  2000       Impact factor: 7.527

8.  Patients co-infected with human immunodeficiency virus and hepatitis C virus demonstrate higher levels of hepatic HCV RNA.

Authors:  M Bonacini; S Govindarajan; L M Blatt; P Schmid; A Conrad; K L Lindsay
Journal:  J Viral Hepat       Date:  1999-05       Impact factor: 3.728

9.  Drinking habits of subjects with hepatitis C virus-related chronic liver disease: prevalence and effect on clinical, virological and pathological aspects.

Authors:  C Loguercio; M Di Pierro; M P Di Marino; A Federico; D Disalvo; E Crafa; C Tuccillo; F Baldi; C del VecchioBlanco
Journal:  Alcohol Alcohol       Date:  2000 May-Jun       Impact factor: 2.826

10.  Increasing hepatitis C virus RNA levels in hemophiliacs: relationship to human immunodeficiency virus infection and liver disease. Multicenter Hemophilia Cohort Study.

Authors:  M E Eyster; M W Fried; A M Di Bisceglie; J J Goedert
Journal:  Blood       Date:  1994-08-15       Impact factor: 22.113
View more
  1 in total

1.  Analytical variables influencing the HCV RNA determination by TaqMan real-time PCR in routine clinical laboratory practice.

Authors:  Abida Raza; Zameer Ali; Javaid Irfan; Shahnaz Murtaza; Samina Shakeel
Journal:  Mol Biol Rep       Date:  2012-02-12       Impact factor: 2.316
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.